Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary – Gujarat Themis Biosyn Limited** Gujarat Themis Biosyn faces critical compliance exposure under SEBI BRSR mandates, with a maximum risk score of 10.0/10 on regulatory obligations; non-disclosure or inadequate ESG reporting could trigger enforcement action and potential delisting risk if the company falls under top-tier listing categories. The company's largest financial exposure stems from EPR (Extended Producer Responsibility) obligations with a 6.5/10 risk score and unknown applicability status—failure to establish product take-back systems could result in penalties and operational disruptions across pharmaceutical packaging streams. At ₹150.8 crore revenue scale, the estimated compliance remediation cost of ₹0–1 crore represents manageable near-term burden, but missing emissions data (Scope 1 & 2 reported as zero) indicates incomplete GHG accounting; this creates hidden liability exposure, as fermentation-based API manufacturing typically generates 2–5 tCO2e per tonne of output, potentially incurring ₹12–45 lakh in unquantified carbon cost
Source: GUJARAT THEMIS BIOSYN LIMITED BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.